跳至主要内容
临床试验/EUCTR2021-003168-28-NL
EUCTR2021-003168-28-NL进行中(未招募)1 期

Impact of Triglyceride-Lowering on Inflammatory Activity in Patients with Hypertriglyceridemia

Academic Medical Center (AMC), department of Internal Medicine0 个研究点目标入组 30 人开始时间: 2022年4月2日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Adults above 18 years old
  • - Triglyceride levels > 4mmol/l (350 mg/dl)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • - Molecularly diagnosed familial chylomicronemia syndrome (homozygous and/or compound heterozygous)
  • - Use of fibrates or fish oil: both have to be discontinued for at least 4 weeks prior to baseline visit
  • - Uncontrolled diabetes (HBa1C > 70 mmol/mol)
  • - Alcohol intake > 4c/day
  • - ASAT/ALAT > 3x ULN
  • - Renal insufficiency, defined as eGFR < 30 ml/min
  • - Platelet count < 150.000 and > 450.000 /mm3
  • - Pancreatitis < 8 weeks prior to baseline visit
  • - Body mass index (BMI) > 35.0 kg/m2
  • - Premenopausal women not using birth-control
  • - Uncontrolled hypertension (systolic > 180 mmHg; diastolic > 105 mmHg)
  • - Diagnosis of (active) malignancy in last 5 years
  • - Any other treatment or clinically relevant condition that could interfere with the conduct or interpretation of the study in the opinion of the investigator
  • - Inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study

研究者

发起方
Academic Medical Center (AMC), department of Internal Medicine

相似试验